HomeLiterature Search
Popular searches
Mutational profiling using liquid biopsy to guide targeted therapy in patients …

Mazouji(O),Ouhajjou(A),Anouar(N),Nejjari(C),… Sci Rep 2025-04-01

...NF1 were the most frequently mutated in our patients. Our study highlights the potential benefits of personalized medici...

Methodology, Criteria, and Characterization of Patient-Matched Thyroid Cell Lin…

Marlow(LA),Rohl(SD),Miller(JL),Knauf(JA),Fag… J Clin Endocrinol Metab 2018-00-01

...NF1, and EIF1AX). We established seven new thyroid cell lines (LAM136, EAM306, SDAR1, SDAR2, JEM493, THJ529, and THJ560)...

Clinical utility of comprehensive genomic profiling test for colorectal cancer:…

Tanabe(H),Ando(K),Takahashi(K),Kamanaka(T),Y… J Cancer Res Clin Oncol 2025-09-10

...NF1 were associated with worse OS. Interestingly, PTEN mutations were linked to improved survival. TP53 alterations were...

Pineal region glioblastomas display features of diffuse midline and non-midline…

D'Amico(RS),Zanazzi(G),Wu(P),Canoll(P),Bruce… J Neurooncol 2018-10-00

...NF1. Adjuvant radiation and chemotherapy was employed in 87.5% and 75.0% of patients, respectively. Median overall survi...

Genomic characterization of patients with colorectal cancer.

Mahdouani(M),Zhuri(D),Dusenkalkan(F),Gurkan(… Hered Cancer Clin Pract 2025-09-26

...NF1, ABRAXAS1, ERBB2, FGFR, and CHEK2, necessitating further investigation to determine their potential role in CRC pred...

Clinical predictors of survival in malignant peripheral nerve sheath tumors of …

LiNa(S),Jianfei(T),Zhifeng(T),Xinbin(W),Hui(… Braz J Otorhinolaryngol 2025-00-00

...NF1 (22%), SMARCB1 (21%), TP53 (12%), SUZ12 (19%), and less commonly in BRAF and CDKN2A (each 2%). Radiotherapy improves...

Germline Cancer Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report…

Li(H),Sisoudiya(SD),Martin-Giacalone(BA),Kha… J Natl Cancer Inst 2021-07-01

...NF1). Notably, 5 patients had well-described oncogenic missense variants in HRAS (p.G12V and p.G12S) associated with Cos...

Acquired Resistance to KRASG12C Inhibition in Cancer.

Awad(MM),Liu(S),Rybkin(II),Arbour(KC),Dilly(… N Engl J Med 2021-00-24

...NF1 and PTEN. In two of nine patients with lung adenocarcinoma for whom paired tissue-biopsy samples were available, his...

The clinicopathologic spectrum and genomic landscape of de-/trans-differentiate…

Ferreira(I),Droop(A),Edwards(O),Wong(K),Harl… Mod Pathol 2021-11-00

...NF1 mutations (5) in the conventional component, which was also detected in the corresponding de-/trans-differentiated c...

Pathogenic Germline Variants in Cancer Susceptibility Genes in Children and You…

Kim(J),Light(N),Subasri(V),Young(EL),Wegman-… JCO Precis Oncol 2021-00-00

...NF1, DICER1, mismatch repair genes), rarely (BRCA2, CBL, CHEK2, SMARCA4), or never (FGFR4) reported in RMS. Numerous gen...

Previous 855 856 857 858 859 860 861 862 863 Next Vol. 859 / of 901 页

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com